145 Views

Highstar Capital-backed Advanced Disposal files for IPO

Advanced Disposal, a provider of solid waste collection, transfer, recycling and disposal services, has filed for an IPO. The number of shares the stock will sell as well as its pricing terms have yet to be set. Deutsche Bank Securities, Credit Suisse and Barclays are serving as the lead underwriters. Advanced Disposal is backed by Highstar Capital.

VC-backed GBT goes public

South San Francisco-based Global Blood Therapeutics Inc, a biopharmaceutical company focused on treating blood-based disorders, has raised $120 million for its IPO after pricing its 6 million shares at $20 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “GBT.” Morgan Stanley and Goldman Sachs are serving as the lead underwriters. GBT’s backers included Wellington Management Company, RA Capital, Deerfield Management, Sabby Capital and Perceptive Life Sciences.

VC-backed Aimmune Therapeutics goes public

Brisbane, California-based Aimmune Therapeutics, a biopharmaceutical company focused on treating peanut allergies, has raised $160 million for its IPO after pricing its 10 million shares at $16 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “AIMT.” BofA Merrill Lynch, Credit Suisse and Piper Jaffray are serving as the lead underwriters. Aimmune’s backers include Longitude Capital, Foresite Capital and Aisling Capital.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget